Korean Drug Co. Ltd (014570) — Cash Flow Reinvestment Rate
Korean Drug Co. Ltd (014570) has a Cash Flow Reinvestment Rate of 0.02x as of March 2026, reinvesting ₩162.97 Million (capex ₩131.88 Million plus investments ₩-31.09 Million) from operating cash flow of ₩6.60 Billion. Check Korean Drug Co. Ltd (014570) cash earnings ratio to evaluate the quality of earnings relative to operating cash generation.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Korean Drug Co. Ltd Cash Flow Reinvestment Rate (2014–2025)
Historical reinvestment intensity for Korean Drug Co. Ltd across 11 annual periods. Explore Korean Drug Co. Ltd long-term investment allocation to see how much of total assets are deployed in long-term investments.
Annual Cash Flow Reinvestment Rate for Korean Drug Co. Ltd (2014–2025)
Year-by-year capital reinvestment analysis for Korean Drug Co. Ltd. For live market cap and broader valuation context, see 014570 stock market capitalisation.
| Year | Reinvestment Rate | Total Reinvested (KRW) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.81x | ₩10.66 Billion | ₩13.11 Billion | ₩475.05 Million | ▼ -66.8% |
| 2024 | 2.45x | ₩11.93 Billion | ₩4.87 Billion | ₩1.04 Billion | ▲ +107.4% |
| 2022 | 1.18x | ₩6.99 Billion | ₩5.91 Billion | ₩6.09 Billion | ▲ +28.1% |
| 2021 | 0.92x | ₩8.13 Billion | ₩8.81 Billion | ₩1.15 Billion | ▲ +6.8% |
| 2020 | 0.86x | ₩10.65 Billion | ₩12.33 Billion | ₩738.47 Million | ▲ +27.3% |
| 2019 | 0.68x | ₩4.21 Billion | ₩6.21 Billion | ₩3.05 Billion | ▲ +19.6% |
| 2018 | 0.57x | ₩3.28 Billion | ₩5.79 Billion | ₩1.30 Billion | ▼ -88.1% |
| 2017 | 4.78x | ₩2.14 Billion | ₩447.20 Million | ₩1.13 Billion | ▲ +1240.0% |
| 2016 | 0.36x | ₩1.41 Billion | ₩3.96 Billion | ₩460.84 Million | ▲ +21.1% |
| 2015 | 0.29x | ₩1.81 Billion | ₩6.13 Billion | ₩878.05 Million | ▲ +143.8% |
| 2014 | 0.12x | ₩539.06 Million | ₩4.46 Billion | ₩538.19 Million | — |